Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Wei Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8263-571X; OpenAlex author ID A5038901231. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2018: 3 papers · 2019: 3 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 7

  1. The platelet pannexin 1-IL-1β axis orchestrates pancreatic ductal adenocarcinoma invasion and metastasis. Co-author DOI 10.1038/s41388-023-02647-0↗
  2. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery. Co-author DOI 10.1002/cam4.1957↗
  3. Angiogenesis in pancreatic cancer: current research status and clinical implications. Co-author DOI 10.1007/s10456-018-9645-2↗
  4. ASO Author Reflections: Tumor-Infiltrating NETs are New Biomarkers to Predict Postsurgical Survival for Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-019-07169-2↗
  5. Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-018-6727-8↗
  6. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling. Co-author DOI 10.3892/ijo.2018.4269↗
  7. The Significance of Liquid Biopsy in Pancreatic Cancer. Co-author DOI 10.7150/jca.24591↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaxiang Xu · 7 shared papers, 2018–2023 · strength 0.70
  2. Xianjun Yu · 6 shared papers, 2018–2019 · strength 0.52
  3. Chuntao Wu · 5 shared papers, 2018–2019 · strength 0.38
  4. Liang Liu · 4 shared papers, 2018–2019 · strength 0.36
  5. Hao Li · 3 shared papers, 2018–2023 · strength 0.34
  6. Shirong Zhang · 3 shared papers, 2018–2023 · strength 0.33
  7. Liang Liu · 2 shared papers, 2019–2023 · strength 0.27
  8. Wen-Quan Wang · 3 shared papers, 2018–2019 · strength 0.23
  9. Zi-Hao Qi · 3 shared papers, 2018–2019 · strength 0.23
  10. He-Li Gao · 3 shared papers, 2018–2019 · strength 0.23
  11. Shi-Rong Zhang · 3 shared papers, 2018–2019 · strength 0.23
  12. Jin-Zhi Xu · 3 shared papers, 2018–2019 · strength 0.23
  13. Quanxing Ni · 3 shared papers, 2018–2019 · strength 0.22
  14. Xian-Jun Yu · 1 shared paper, 2023 · strength 0.18
  15. Heli Gao · 2 shared papers, 2018–2019 · strength 0.15
  16. Shuo Li · 2 shared papers, 2018–2019 · strength 0.15
  17. Wenquan Wang · 2 shared papers, 2018–2019 · strength 0.15
  18. Shuo Li · 1 shared paper, 2019 · strength 0.08
  19. Wuhu Zhang · 1 shared paper, 2019 · strength 0.08
  20. Tianjiao Li · 1 shared paper, 2019 · strength 0.08
  21. Liang Liu · 1 shared paper, 2018 · strength 0.07
  22. Lie Yao · 1 shared paper, 2018 · strength 0.07
  23. Deliang Fu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.